Carcinoid syndrome (CS) is a rare condition associated with neuroendocrine tumors (NETs), particularly those originating in the gastrointestinal tract, which secrete bioactive substances like serotonin. The management of CS requires a multidisciplinary approach due to its complex clinical manifestations, including flushing, diarrhea, bronchospasm, and carcinoid heart disease. Optimal care involves collaboration between several professional figures like oncologists, endocrinologists, gastroenterologists, surgeons, and dietitians. Currently, a wide range of treatments are available, focused on both symptom control and tumor burden reduction. Somatostatin analogs (SSAs) are the first-line therapy for symptom relief. Still, in patients with progressive disease or refractory CS, other options include targeted therapies, peptide receptor radionuclide therapy (PRRT), liver-directed therapies, and surgical resection, when feasible. Furthermore, management of complications related to prolonged serotonin release and malnutrition as a result of exocrine pancreatic insufficiency, post-surgical conditions, vitamin deficit, and chronic diarrhea often requires early detection to mitigate symptoms and improve the quality of life in these patients. The complexity of CS necessitates individualized care and continuous coordination among specialists to optimize outcomes and enhance patient well-being.
类癌综合征是一种罕见的疾病，与神经内分泌肿瘤相关，尤其多见于起源于胃肠道的肿瘤，这些肿瘤会分泌血清素等生物活性物质。由于其临床表现复杂，包括潮红、腹泻、支气管痉挛和类癌心脏病等，类癌综合征的治疗需要多学科协作。最佳治疗方案需要肿瘤科医生、内分泌科医生、胃肠病科医生、外科医生和营养师等多个专业人员的合作。目前，已有多种治疗方法可供选择，主要集中在症状控制和减少肿瘤负荷两方面。生长抑素类似物是缓解症状的一线疗法。然而，对于疾病进展或难治性类癌综合征患者，其他可选方案包括靶向治疗、肽受体放射性核素治疗、肝脏导向治疗以及在可行情况下的手术切除。此外，对于因长期血清素释放、胰腺外分泌功能不全、术后状况、维生素缺乏和慢性腹泻等引起的并发症及营养不良，通常需要早期发现以缓解症状并改善患者的生活质量。类癌综合征的复杂性要求个体化治疗和专科医生之间的持续协调，以优化治疗效果并提升患者的健康状况。
肿瘤(癌症)患者之家